Nkure Therapeutics

Private

Bangalore UrbanHealthcare & Life Scienceshttps://www.nkure.com/

Last Round

Pre Seed

Apr 26, 2023

Company Overview

Nkure Therapeutics is a biotechnology company developing affordable natural killer (NK) cell-based immunotherapies for cancer and infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

natural killer cell therapyNK cell therapyallogeneic cell therapyoff-the-shelf therapycell-based immunotherapygene-edited cellsoncology biotechcancer immunotherapyhematological malignanciessolid tumor treatmentpreclinical drug developmentoff-the-shelf medicinenext-gen immunotherapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nkure Therapeutics Comparables

Compare Nkure Therapeutics with similar companies based on industry and business-model similarity.

Nkure Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Nkure Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Pre Seed	Apr 26, 2023

View all Funding Rounds

Nkure Therapeutics Investors

Notable investors and investment history

Nkure Therapeutics investors
Investor	Rounds
Endiya Partners	Pre Seed
Innovative Quest Private Limited	Pre Seed
Kotak Alternate Asset Managers	Pre Seed
Department of Biotechnology	Pre Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 7, 2025
Partnering with CRISPR Therapeutics to co-develop CAR T therapy CTX112(TM).
May 7, 2025
Partnering with CRISPR Therapeutics to co-develop CAR T therapy for oncology.

View all signals

Nkure Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Nkure Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nkure Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBangalore Urban

Employee Range13

Year Founded2021

Last FundingApr 26, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.